

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.78450474 |
| 2 | negative regulation of cell killing (GO:0031342) | 5.69252869 |
| 3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.69252869 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.62828806 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.62828806 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 5.62828806 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 5.62828806 |
| 8 | modulation by symbiont of host defense response (GO:0052031) | 5.62828806 |
| 9 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.62828806 |
| 10 | detection of other organism (GO:0098543) | 5.15707597 |
| 11 | detection of bacterium (GO:0016045) | 5.03693131 |
| 12 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.01071595 |
| 13 | macrophage activation involved in immune response (GO:0002281) | 4.76289513 |
| 14 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.52938079 |
| 15 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.43725774 |
| 16 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.43354514 |
| 17 | response to peptidoglycan (GO:0032494) | 4.41912486 |
| 18 | detection of external biotic stimulus (GO:0098581) | 4.37763372 |
| 19 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.37681010 |
| 20 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.37681010 |
| 21 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.31535944 |
| 22 | negative regulation of interleukin-12 production (GO:0032695) | 4.13391535 |
| 23 | regulation of gamma-delta T cell activation (GO:0046643) | 4.07575711 |
| 24 | detection of molecule of bacterial origin (GO:0032490) | 4.06017335 |
| 25 | protoporphyrinogen IX metabolic process (GO:0046501) | 4.02008497 |
| 26 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.01978256 |
| 27 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.99464750 |
| 28 | granulocyte activation (GO:0036230) | 3.94969089 |
| 29 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.93842537 |
| 30 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.90312519 |
| 31 | leukocyte aggregation (GO:0070486) | 3.83524869 |
| 32 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.82761458 |
| 33 | response to host immune response (GO:0052572) | 3.82761458 |
| 34 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.81836664 |
| 35 | detection of biotic stimulus (GO:0009595) | 3.79637897 |
| 36 | regulation of mast cell degranulation (GO:0043304) | 3.76441805 |
| 37 | immunoglobulin mediated immune response (GO:0016064) | 3.70289490 |
| 38 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.67813769 |
| 39 | L-phenylalanine catabolic process (GO:0006559) | 3.67813769 |
| 40 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.66720623 |
| 41 | L-phenylalanine metabolic process (GO:0006558) | 3.66720623 |
| 42 | myeloid cell activation involved in immune response (GO:0002275) | 3.63274383 |
| 43 | microglial cell activation (GO:0001774) | 3.59305801 |
| 44 | response to host (GO:0075136) | 3.55070048 |
| 45 | response to host defenses (GO:0052200) | 3.55070048 |
| 46 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.55070048 |
| 47 | negative regulation of T cell mediated immunity (GO:0002710) | 3.54084112 |
| 48 | defense response to fungus (GO:0050832) | 3.49244250 |
| 49 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.48494665 |
| 50 | regulation of T cell tolerance induction (GO:0002664) | 3.47856605 |
| 51 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.47191009 |
| 52 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.47191009 |
| 53 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 3.46486056 |
| 54 | macrophage activation (GO:0042116) | 3.45847796 |
| 55 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.45103436 |
| 56 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.44263326 |
| 57 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.43675924 |
| 58 | cellular response to type I interferon (GO:0071357) | 3.42881695 |
| 59 | type I interferon signaling pathway (GO:0060337) | 3.42881695 |
| 60 | pentose-phosphate shunt (GO:0006098) | 3.41886285 |
| 61 | negative regulation of phagocytosis (GO:0050765) | 3.41615960 |
| 62 | response to type I interferon (GO:0034340) | 3.40785514 |
| 63 | regulation of leukocyte degranulation (GO:0043300) | 3.36359705 |
| 64 | killing of cells of other organism (GO:0031640) | 3.33964889 |
| 65 | disruption of cells of other organism (GO:0044364) | 3.33964889 |
| 66 | germinal center formation (GO:0002467) | 3.33342290 |
| 67 | leukocyte degranulation (GO:0043299) | 3.33068566 |
| 68 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.30248507 |
| 69 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.29749914 |
| 70 | regulation of tolerance induction (GO:0002643) | 3.27278658 |
| 71 | oxaloacetate metabolic process (GO:0006107) | 3.27066638 |
| 72 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.21469793 |
| 73 | response to muramyl dipeptide (GO:0032495) | 3.20879895 |
| 74 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.16861167 |
| 75 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.15877284 |
| 76 | regulation of mast cell activation (GO:0033003) | 3.15422288 |
| 77 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.15236148 |
| 78 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.15236148 |
| 79 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.14957086 |
| 80 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.14957086 |
| 81 | alpha-linolenic acid metabolic process (GO:0036109) | 3.14055710 |
| 82 | plasma lipoprotein particle assembly (GO:0034377) | 3.12027800 |
| 83 | negative regulation of type 2 immune response (GO:0002829) | 3.06362096 |
| 84 | cellular extravasation (GO:0045123) | 3.04864718 |
| 85 | NADPH regeneration (GO:0006740) | 3.04611593 |
| 86 | regulation of regulated secretory pathway (GO:1903305) | 3.03809351 |
| 87 | negative regulation of innate immune response (GO:0045824) | 3.02748674 |
| 88 | aromatic amino acid family catabolic process (GO:0009074) | 3.00983621 |
| 89 | neutrophil mediated immunity (GO:0002446) | 3.00585503 |
| 90 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.00426512 |
| 91 | respiratory burst (GO:0045730) | 2.99905373 |
| 92 | porphyrin-containing compound biosynthetic process (GO:0006779) | 2.99813616 |
| 93 | heme biosynthetic process (GO:0006783) | 2.98713433 |
| 94 | valine metabolic process (GO:0006573) | 2.98575862 |
| 95 | negative regulation of interleukin-6 production (GO:0032715) | 2.97658769 |
| 96 | tolerance induction (GO:0002507) | 2.97230881 |
| 97 | kynurenine metabolic process (GO:0070189) | 2.96159587 |
| 98 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.94787368 |
| 99 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.94005554 |
| 100 | dendritic cell chemotaxis (GO:0002407) | 2.93669042 |
| 101 | B cell receptor signaling pathway (GO:0050853) | 2.93103364 |
| 102 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.91064787 |
| 103 | erythrocyte maturation (GO:0043249) | 2.90492907 |
| 104 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.90386932 |
| 105 | dendritic cell migration (GO:0036336) | 2.89925640 |
| 106 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.88243639 |
| 107 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.88169083 |
| 108 | B cell mediated immunity (GO:0019724) | 2.87379314 |
| 109 | regulation of B cell differentiation (GO:0045577) | 2.86906667 |
| 110 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.85955847 |
| 111 | regulation of regulatory T cell differentiation (GO:0045589) | 2.85398881 |
| 112 | protein-lipid complex assembly (GO:0065005) | 2.84693463 |
| 113 | lysine metabolic process (GO:0006553) | 2.84270935 |
| 114 | lysine catabolic process (GO:0006554) | 2.84270935 |
| 115 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.82990635 |
| 116 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.82776645 |
| 117 | urea metabolic process (GO:0019627) | 2.80626053 |
| 118 | urea cycle (GO:0000050) | 2.80626053 |
| 119 | response to interleukin-15 (GO:0070672) | 2.79007035 |
| 120 | positive thymic T cell selection (GO:0045059) | 2.78018623 |
| 121 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.77332749 |
| 122 | imidazole-containing compound metabolic process (GO:0052803) | 2.75909002 |
| 123 | positive regulation of mast cell activation (GO:0033005) | 2.75604303 |
| 124 | positive regulation of B cell differentiation (GO:0045579) | 2.75365723 |
| 125 | tryptophan catabolic process (GO:0006569) | 2.74796189 |
| 126 | indole-containing compound catabolic process (GO:0042436) | 2.74796189 |
| 127 | indolalkylamine catabolic process (GO:0046218) | 2.74796189 |
| 128 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.72666830 |
| 129 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.72188971 |
| 130 | 2-oxoglutarate metabolic process (GO:0006103) | 2.71932274 |
| 131 | glyoxylate metabolic process (GO:0046487) | 2.71442376 |
| 132 | tetrapyrrole biosynthetic process (GO:0033014) | 2.70754283 |
| 133 | porphyrin-containing compound metabolic process (GO:0006778) | 2.67035117 |
| 134 | positive regulation of isotype switching (GO:0045830) | 2.65370004 |
| 135 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.64884524 |
| 136 | heme metabolic process (GO:0042168) | 2.63744140 |
| 137 | neutrophil activation involved in immune response (GO:0002283) | 2.63191092 |
| 138 | sulfur amino acid catabolic process (GO:0000098) | 2.62552828 |
| 139 | high-density lipoprotein particle remodeling (GO:0034375) | 2.59634269 |
| 140 | response to fungus (GO:0009620) | 2.56620890 |
| 141 | phospholipid efflux (GO:0033700) | 2.55632911 |
| 142 | defense response to protozoan (GO:0042832) | 2.54579519 |
| 143 | nitrogen cycle metabolic process (GO:0071941) | 2.53019519 |
| 144 | barbed-end actin filament capping (GO:0051016) | 2.50785053 |
| 145 | negative T cell selection (GO:0043383) | 2.48162368 |
| 146 | positive T cell selection (GO:0043368) | 2.47520073 |
| 147 | tryptophan metabolic process (GO:0006568) | 2.47424148 |
| 148 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.43677096 |
| 149 | myeloid leukocyte mediated immunity (GO:0002444) | 2.42649944 |
| 150 | plasma lipoprotein particle organization (GO:0071827) | 2.42618432 |
| 151 | neutrophil activation (GO:0042119) | 2.42376224 |
| 152 | phospholipid homeostasis (GO:0055091) | 2.41539555 |
| 153 | negative regulation of fibrinolysis (GO:0051918) | 2.41432822 |
| 154 | leukotriene biosynthetic process (GO:0019370) | 2.40333443 |
| 155 | ethanol oxidation (GO:0006069) | 2.40224075 |
| 156 | tricarboxylic acid metabolic process (GO:0072350) | 2.38455365 |
| 157 | oxygen transport (GO:0015671) | 2.38310569 |
| 158 | aldehyde catabolic process (GO:0046185) | 2.37366538 |
| 159 | negative thymic T cell selection (GO:0045060) | 2.35230287 |
| 160 | bile acid biosynthetic process (GO:0006699) | 2.34929768 |
| 161 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.34360322 |
| 162 | cellular response to interleukin-15 (GO:0071350) | 2.34030648 |
| 163 | positive regulation of DNA recombination (GO:0045911) | 2.33647513 |
| 164 | negative regulation of protein oligomerization (GO:0032460) | 2.33474730 |
| 165 | glucose catabolic process (GO:0006007) | 2.32629204 |
| 166 | amino-acid betaine metabolic process (GO:0006577) | 2.32033019 |
| 167 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.31969483 |
| 168 | protein-lipid complex subunit organization (GO:0071825) | 2.31224906 |
| 169 | NADP metabolic process (GO:0006739) | 2.31057973 |
| 170 | mast cell activation (GO:0045576) | 2.30187057 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.04766270 |
| 2 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.89044133 |
| 3 | MYC_22102868_ChIP-Seq_BL_Human | 2.78140753 |
| 4 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.73908032 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.61479310 |
| 6 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.61045202 |
| 7 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.55735806 |
| 8 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.55019681 |
| 9 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.51023032 |
| 10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.42550319 |
| 11 | GATA1_22025678_ChIP-Seq_K562_Human | 2.31287138 |
| 12 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.23827145 |
| 13 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.23153106 |
| 14 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.20455908 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.12185970 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.11681284 |
| 17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.11665319 |
| 18 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.08916450 |
| 19 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.08124262 |
| 20 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.03530036 |
| 21 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.02619536 |
| 22 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.00517691 |
| 23 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.99849477 |
| 24 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.97487525 |
| 25 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.95172867 |
| 26 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.94810451 |
| 27 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.93997834 |
| 28 | MAF_26560356_Chip-Seq_TH1_Human | 1.88035488 |
| 29 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.87330887 |
| 30 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.84441366 |
| 31 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.83855376 |
| 32 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.82951980 |
| 33 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.82287183 |
| 34 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.79716576 |
| 35 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.79439529 |
| 36 | UTX_26944678_Chip-Seq_JUKART_Human | 1.78313295 |
| 37 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.77238209 |
| 38 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.77073105 |
| 39 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76651904 |
| 40 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.74037669 |
| 41 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.73265886 |
| 42 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.71994069 |
| 43 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71945558 |
| 44 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.66556200 |
| 45 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.64612287 |
| 46 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.64478701 |
| 47 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.63199299 |
| 48 | SPI1_23127762_ChIP-Seq_K562_Human | 1.60055185 |
| 49 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.59131826 |
| 50 | MYB_26560356_Chip-Seq_TH1_Human | 1.59067672 |
| 51 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.58810962 |
| 52 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.58290428 |
| 53 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.57159678 |
| 54 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.55594810 |
| 55 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.55445693 |
| 56 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.55388687 |
| 57 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.55158758 |
| 58 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.51992676 |
| 59 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.50974846 |
| 60 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.50714467 |
| 61 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.47444137 |
| 62 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.47145497 |
| 63 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45420378 |
| 64 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45376479 |
| 65 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.43493023 |
| 66 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.42330468 |
| 67 | MAF_26560356_Chip-Seq_TH2_Human | 1.42101379 |
| 68 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.41952870 |
| 69 | MYB_26560356_Chip-Seq_TH2_Human | 1.41743768 |
| 70 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.41249026 |
| 71 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.40194868 |
| 72 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.37887051 |
| 73 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.37853568 |
| 74 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.37320488 |
| 75 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.35742808 |
| 76 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.35666016 |
| 77 | GATA1_19941826_ChIP-Seq_K562_Human | 1.35633001 |
| 78 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.35377843 |
| 79 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.35100272 |
| 80 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.34063243 |
| 81 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.33583515 |
| 82 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.32629573 |
| 83 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.30194591 |
| 84 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.29357322 |
| 85 | P68_20966046_ChIP-Seq_HELA_Human | 1.26904824 |
| 86 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.25793452 |
| 87 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.24542333 |
| 88 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.24078433 |
| 89 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.22813975 |
| 90 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20964330 |
| 91 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20697695 |
| 92 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.19734423 |
| 93 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16911899 |
| 94 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.16794116 |
| 95 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.16218274 |
| 96 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15987694 |
| 97 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14517503 |
| 98 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.13080532 |
| 99 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.12272341 |
| 100 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.12211294 |
| 101 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11549429 |
| 102 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.09110183 |
| 103 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08723014 |
| 104 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.08386719 |
| 105 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.08362093 |
| 106 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.07749794 |
| 107 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.07420276 |
| 108 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.06905140 |
| 109 | GATA2_19941826_ChIP-Seq_K562_Human | 1.06775601 |
| 110 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.06659270 |
| 111 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.06000188 |
| 112 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.05497057 |
| 113 | GATA3_26560356_Chip-Seq_TH2_Human | 1.04093306 |
| 114 | KDM2B_26808549_Chip-Seq_K562_Human | 1.03853924 |
| 115 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.01891568 |
| 116 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.00993070 |
| 117 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.99956307 |
| 118 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.98237354 |
| 119 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.98096662 |
| 120 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.97993030 |
| 121 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97949140 |
| 122 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.97700796 |
| 123 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97302638 |
| 124 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.96997426 |
| 125 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96232203 |
| 126 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.96051778 |
| 127 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.96004141 |
| 128 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94250229 |
| 129 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.89546718 |
| 130 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.89362984 |
| 131 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.86597048 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003656_abnormal_erythrocyte_physiolo | 4.04026134 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 2.93086299 |
| 3 | MP0005360_urolithiasis | 2.92694761 |
| 4 | MP0003436_decreased_susceptibility_to | 2.69216441 |
| 5 | MP0005365_abnormal_bile_salt | 2.63811779 |
| 6 | MP0005671_abnormal_response_to | 2.50380058 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 2.47932823 |
| 8 | MP0009840_abnormal_foam_cell | 2.37321341 |
| 9 | MP0002837_dystrophic_cardiac_calcinosis | 2.29925118 |
| 10 | MP0009785_altered_susceptibility_to | 2.28362070 |
| 11 | MP0005085_abnormal_gallbladder_physiolo | 2.28048242 |
| 12 | MP0003191_abnormal_cellular_cholesterol | 2.17640567 |
| 13 | MP0001835_abnormal_antigen_presentation | 2.02866420 |
| 14 | MP0010329_abnormal_lipoprotein_level | 2.02638117 |
| 15 | MP0009278_abnormal_bone_marrow | 2.00415402 |
| 16 | MP0002419_abnormal_innate_immunity | 1.98108119 |
| 17 | MP0005464_abnormal_platelet_physiology | 1.92985624 |
| 18 | MP0008875_abnormal_xenobiotic_pharmacok | 1.92701741 |
| 19 | MP0005397_hematopoietic_system_phenotyp | 1.89692723 |
| 20 | MP0001545_abnormal_hematopoietic_system | 1.89692723 |
| 21 | MP0001800_abnormal_humoral_immune | 1.88950519 |
| 22 | MP0003763_abnormal_thymus_physiology | 1.88929557 |
| 23 | MP0003303_peritoneal_inflammation | 1.86488089 |
| 24 | MP0005025_abnormal_response_to | 1.85309432 |
| 25 | MP0000685_abnormal_immune_system | 1.83702355 |
| 26 | MP0002398_abnormal_bone_marrow | 1.81967294 |
| 27 | MP0005083_abnormal_biliary_tract | 1.76127862 |
| 28 | MP0002396_abnormal_hematopoietic_system | 1.75948719 |
| 29 | MP0003172_abnormal_lysosome_physiology | 1.75487904 |
| 30 | MP0003828_pulmonary_edema | 1.73258251 |
| 31 | MP0002420_abnormal_adaptive_immunity | 1.69765889 |
| 32 | MP0005000_abnormal_immune_tolerance | 1.69745140 |
| 33 | MP0001819_abnormal_immune_cell | 1.67787325 |
| 34 | MP0002405_respiratory_system_inflammati | 1.66529847 |
| 35 | MP0001790_abnormal_immune_system | 1.66492142 |
| 36 | MP0005387_immune_system_phenotype | 1.66492142 |
| 37 | MP0000689_abnormal_spleen_morphology | 1.65986557 |
| 38 | MP0002723_abnormal_immune_serum | 1.64797704 |
| 39 | MP0001764_abnormal_homeostasis | 1.63627869 |
| 40 | MP0006082_CNS_inflammation | 1.62186885 |
| 41 | MP0000609_abnormal_liver_physiology | 1.59765938 |
| 42 | MP0000716_abnormal_immune_system | 1.57232306 |
| 43 | MP0004147_increased_porphyrin_level | 1.55553645 |
| 44 | MP0001873_stomach_inflammation | 1.55227691 |
| 45 | MP0002722_abnormal_immune_system | 1.53956643 |
| 46 | MP0002452_abnormal_antigen_presenting | 1.53815247 |
| 47 | MP0005451_abnormal_body_composition | 1.53127638 |
| 48 | MP0004381_abnormal_hair_follicle | 1.52094900 |
| 49 | MP0002735_abnormal_chemical_nociception | 1.50829058 |
| 50 | MP0002277_abnormal_respiratory_mucosa | 1.50109514 |
| 51 | MP0005166_decreased_susceptibility_to | 1.47025988 |
| 52 | MP0002429_abnormal_blood_cell | 1.44588181 |
| 53 | MP0001845_abnormal_inflammatory_respons | 1.44304537 |
| 54 | MP0003724_increased_susceptibility_to | 1.41690448 |
| 55 | MP0006036_abnormal_mitochondrial_physio | 1.40798620 |
| 56 | MP0001851_eye_inflammation | 1.38743749 |
| 57 | MP0005058_abnormal_lysosome_morphology | 1.37611917 |
| 58 | MP0009333_abnormal_splenocyte_physiolog | 1.37494121 |
| 59 | MP0008469_abnormal_protein_level | 1.36969653 |
| 60 | MP0009764_decreased_sensitivity_to | 1.34315296 |
| 61 | MP0005174_abnormal_tail_pigmentation | 1.34309819 |
| 62 | MP0001853_heart_inflammation | 1.34061150 |
| 63 | MP0002132_abnormal_respiratory_system | 1.31970197 |
| 64 | MP0003075_altered_response_to | 1.30714907 |
| 65 | MP0005319_abnormal_enzyme/_coenzyme | 1.28866216 |
| 66 | MP0004883_abnormal_blood_vessel | 1.28728107 |
| 67 | MP0000858_altered_metastatic_potential | 1.27857274 |
| 68 | MP0005310_abnormal_salivary_gland | 1.26418507 |
| 69 | MP0002998_abnormal_bone_remodeling | 1.24719048 |
| 70 | MP0000703_abnormal_thymus_morphology | 1.22313500 |
| 71 | MP0002148_abnormal_hypersensitivity_rea | 1.21955354 |
| 72 | MP0003690_abnormal_glial_cell | 1.18769418 |
| 73 | MP0002822_catalepsy | 1.17224869 |
| 74 | MP0004947_skin_inflammation | 1.17207341 |
| 75 | MP0002118_abnormal_lipid_homeostasis | 1.16853703 |
| 76 | MP0010155_abnormal_intestine_physiology | 1.16211362 |
| 77 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.14918528 |
| 78 | MP0008260_abnormal_autophagy | 1.09453834 |
| 79 | MP0004808_abnormal_hematopoietic_stem | 1.09073545 |
| 80 | MP0005332_abnormal_amino_acid | 1.07724651 |
| 81 | MP0004130_abnormal_muscle_cell | 1.07253136 |
| 82 | MP0002166_altered_tumor_susceptibility | 1.05806309 |
| 83 | MP0005164_abnormal_response_to | 1.04489919 |
| 84 | MP0003183_abnormal_peptide_metabolism | 1.02939698 |
| 85 | MP0001533_abnormal_skeleton_physiology | 1.02566865 |
| 86 | MP0000343_altered_response_to | 1.01230010 |
| 87 | MP0009765_abnormal_xenobiotic_induced | 1.01104883 |
| 88 | MP0003252_abnormal_bile_duct | 0.98035674 |
| 89 | MP0003866_abnormal_defecation | 0.97700966 |
| 90 | MP0008004_abnormal_stomach_pH | 0.97648394 |
| 91 | MP0000598_abnormal_liver_morphology | 0.96272792 |
| 92 | MP0003186_abnormal_redox_activity | 0.96256213 |
| 93 | MP0000465_gastrointestinal_hemorrhage | 0.95735738 |
| 94 | MP0005390_skeleton_phenotype | 0.95343959 |
| 95 | MP0005075_abnormal_melanosome_morpholog | 0.93832092 |
| 96 | MP0008874_decreased_physiological_sensi | 0.92448735 |
| 97 | MP0001986_abnormal_taste_sensitivity | 0.92210357 |
| 98 | MP0001666_abnormal_nutrient_absorption | 0.91723610 |
| 99 | MP0000604_amyloidosis | 0.91532025 |
| 100 | MP0004510_myositis | 0.91122364 |
| 101 | MP0001663_abnormal_digestive_system | 0.89722050 |
| 102 | MP0005167_abnormal_blood-brain_barrier | 0.89461496 |
| 103 | MP0002138_abnormal_hepatobiliary_system | 0.87131316 |
| 104 | MP0009643_abnormal_urine_homeostasis | 0.86295254 |
| 105 | MP0009763_increased_sensitivity_to | 0.85145305 |
| 106 | MP0003045_fibrosis | 0.84629892 |
| 107 | MP0005636_abnormal_mineral_homeostasis | 0.82949418 |
| 108 | MP0003448_altered_tumor_morphology | 0.82574475 |
| 109 | MP0000490_abnormal_crypts_of | 0.81820016 |
| 110 | MP0000015_abnormal_ear_pigmentation | 0.81680135 |
| 111 | MP0002019_abnormal_tumor_incidence | 0.80802198 |
| 112 | MP0005377_hearing/vestibular/ear_phenot | 0.79434497 |
| 113 | MP0003878_abnormal_ear_physiology | 0.79434497 |
| 114 | MP0009642_abnormal_blood_homeostasis | 0.76343019 |
| 115 | MP0004858_abnormal_nervous_system | 0.75895730 |
| 116 | MP0003300_gastrointestinal_ulcer | 0.73288384 |
| 117 | MP0003329_amyloid_beta_deposits | 0.72575513 |
| 118 | MP0002933_joint_inflammation | 0.70204932 |
| 119 | MP0003638_abnormal_response/metabolism_ | 0.68141392 |
| 120 | MP0008569_lethality_at_weaning | 0.68123654 |
| 121 | MP0003795_abnormal_bone_structure | 0.66962060 |
| 122 | MP0000249_abnormal_blood_vessel | 0.66197464 |
| 123 | MP0001958_emphysema | 0.65319042 |
| 124 | MP0002133_abnormal_respiratory_system | 0.58055280 |
| 125 | MP0005388_respiratory_system_phenotype | 0.58055280 |
| 126 | MP0003705_abnormal_hypodermis_morpholog | 0.57209591 |
| 127 | MP0000920_abnormal_myelination | 0.56972415 |
| 128 | MP0002332_abnormal_exercise_endurance | 0.53420119 |
| 129 | MP0005535_abnormal_body_temperature | 0.52088937 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Orchitis (HP:0100796) | 5.49824352 |
| 2 | Retrobulbar optic neuritis (HP:0100654) | 5.03111603 |
| 3 | Optic neuritis (HP:0100653) | 5.03111603 |
| 4 | Eczematoid dermatitis (HP:0000976) | 4.34558340 |
| 5 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.96703790 |
| 6 | Increased IgE level (HP:0003212) | 3.86460122 |
| 7 | Recurrent abscess formation (HP:0002722) | 3.82999500 |
| 8 | Keratoconjunctivitis sicca (HP:0001097) | 3.70371410 |
| 9 | Encephalitis (HP:0002383) | 3.70033752 |
| 10 | Recurrent bacterial skin infections (HP:0005406) | 3.45437043 |
| 11 | Keratoconjunctivitis (HP:0001096) | 3.42771487 |
| 12 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.42609603 |
| 13 | Vasculitis (HP:0002633) | 3.37874462 |
| 14 | Hyperlipoproteinemia (HP:0010980) | 3.26160498 |
| 15 | Chest pain (HP:0100749) | 3.23620135 |
| 16 | Episodic fever (HP:0001954) | 3.20951702 |
| 17 | Poikilocytosis (HP:0004447) | 3.12344488 |
| 18 | Hyperbilirubinemia (HP:0002904) | 3.11201339 |
| 19 | T lymphocytopenia (HP:0005403) | 3.00347984 |
| 20 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.98098520 |
| 21 | Deep venous thrombosis (HP:0002625) | 2.96993080 |
| 22 | Recurrent fungal infections (HP:0002841) | 2.92191381 |
| 23 | Abnormality of T cell number (HP:0011839) | 2.91624975 |
| 24 | Hemoptysis (HP:0002105) | 2.88751188 |
| 25 | Peritonitis (HP:0002586) | 2.83241333 |
| 26 | Pulmonary infiltrates (HP:0002113) | 2.82885084 |
| 27 | Spontaneous hematomas (HP:0007420) | 2.79575103 |
| 28 | Reticulocytosis (HP:0001923) | 2.76842088 |
| 29 | Hypoplasia of the thymus (HP:0000778) | 2.74343671 |
| 30 | Cholelithiasis (HP:0001081) | 2.71425320 |
| 31 | Xanthomatosis (HP:0000991) | 2.68263448 |
| 32 | Anorexia (HP:0002039) | 2.64371397 |
| 33 | Amyloidosis (HP:0011034) | 2.64030536 |
| 34 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.62326572 |
| 35 | Abnormal gallbladder morphology (HP:0012437) | 2.61788194 |
| 36 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.59505164 |
| 37 | Arterial thrombosis (HP:0004420) | 2.59332339 |
| 38 | Joint hemorrhage (HP:0005261) | 2.59299198 |
| 39 | Urticaria (HP:0001025) | 2.58570583 |
| 40 | Panhypogammaglobulinemia (HP:0003139) | 2.57651831 |
| 41 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.55281934 |
| 42 | Increased IgM level (HP:0003496) | 2.54408180 |
| 43 | Purpura (HP:0000979) | 2.54043080 |
| 44 | Hypobetalipoproteinemia (HP:0003563) | 2.52666507 |
| 45 | Ketosis (HP:0001946) | 2.52254871 |
| 46 | Epistaxis (HP:0000421) | 2.51136632 |
| 47 | Recurrent skin infections (HP:0001581) | 2.49882066 |
| 48 | Hypochromic microcytic anemia (HP:0004840) | 2.48218043 |
| 49 | Osteomyelitis (HP:0002754) | 2.47775084 |
| 50 | Mediastinal lymphadenopathy (HP:0100721) | 2.47406409 |
| 51 | Microcytic anemia (HP:0001935) | 2.46081435 |
| 52 | Increased cerebral lipofuscin (HP:0011813) | 2.46002714 |
| 53 | Petechiae (HP:0000967) | 2.45130170 |
| 54 | Abnormality of macrophages (HP:0004311) | 2.44113168 |
| 55 | Gingivitis (HP:0000230) | 2.43329511 |
| 56 | Abnormal gallbladder physiology (HP:0012438) | 2.39953936 |
| 57 | Cholecystitis (HP:0001082) | 2.39953936 |
| 58 | Joint swelling (HP:0001386) | 2.37550754 |
| 59 | Sepsis (HP:0100806) | 2.36103326 |
| 60 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.35921334 |
| 61 | Polygenic inheritance (HP:0010982) | 2.35214884 |
| 62 | Gingival bleeding (HP:0000225) | 2.34435717 |
| 63 | Lymphopenia (HP:0001888) | 2.33790043 |
| 64 | Obstructive lung disease (HP:0006536) | 2.32403741 |
| 65 | Chronic obstructive pulmonary disease (HP:0006510) | 2.32403741 |
| 66 | Abnormal platelet volume (HP:0011876) | 2.30830412 |
| 67 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.29044950 |
| 68 | Prolonged bleeding time (HP:0003010) | 2.28949374 |
| 69 | Hepatosplenomegaly (HP:0001433) | 2.28350058 |
| 70 | Hypochromic anemia (HP:0001931) | 2.27268728 |
| 71 | Autoimmune thrombocytopenia (HP:0001973) | 2.25425916 |
| 72 | Combined immunodeficiency (HP:0005387) | 2.24560684 |
| 73 | Abnormality of the pleura (HP:0002103) | 2.24321995 |
| 74 | Hypergammaglobulinemia (HP:0010702) | 2.22970267 |
| 75 | Recurrent viral infections (HP:0004429) | 2.22935275 |
| 76 | Hyperammonemia (HP:0001987) | 2.22858616 |
| 77 | Meningitis (HP:0001287) | 2.20551926 |
| 78 | Colitis (HP:0002583) | 2.19322629 |
| 79 | Prolonged partial thromboplastin time (HP:0003645) | 2.19066494 |
| 80 | Hypercholesterolemia (HP:0003124) | 2.18580149 |
| 81 | Slow saccadic eye movements (HP:0000514) | 2.16860841 |
| 82 | Severe combined immunodeficiency (HP:0004430) | 2.16216050 |
| 83 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.15321933 |
| 84 | Thyroiditis (HP:0100646) | 2.15294970 |
| 85 | Limb hypertonia (HP:0002509) | 2.15276578 |
| 86 | Intrahepatic cholestasis (HP:0001406) | 2.14447976 |
| 87 | Gangrene (HP:0100758) | 2.13816747 |
| 88 | Stomatitis (HP:0010280) | 2.13298538 |
| 89 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.12660176 |
| 90 | Abnormality of the peritoneum (HP:0002585) | 2.12313699 |
| 91 | Myositis (HP:0100614) | 2.11894144 |
| 92 | Complement deficiency (HP:0004431) | 2.10602327 |
| 93 | Cerebral palsy (HP:0100021) | 2.09893431 |
| 94 | Acne (HP:0001061) | 2.07998017 |
| 95 | Abnormality of T cell physiology (HP:0011840) | 2.06992654 |
| 96 | Abnormality of the endocardium (HP:0004306) | 2.05618170 |
| 97 | Glomerulopathy (HP:0100820) | 2.05536308 |
| 98 | Systemic lupus erythematosus (HP:0002725) | 2.05315468 |
| 99 | Premature loss of primary teeth (HP:0006323) | 2.04144066 |
| 100 | Abnormality of T cells (HP:0002843) | 2.03321496 |
| 101 | Gastrointestinal infarctions (HP:0005244) | 2.02765979 |
| 102 | Vacuolated lymphocytes (HP:0001922) | 2.02330782 |
| 103 | Cellulitis (HP:0100658) | 2.02242292 |
| 104 | Leukocytosis (HP:0001974) | 2.01239182 |
| 105 | Papilledema (HP:0001085) | 2.01148794 |
| 106 | Skin ulcer (HP:0200042) | 2.00829647 |
| 107 | Abnormality of iron homeostasis (HP:0011031) | 1.99299869 |
| 108 | Loss of speech (HP:0002371) | 1.98730976 |
| 109 | Vertigo (HP:0002321) | 1.98541429 |
| 110 | Abnormality of the pericardium (HP:0001697) | 1.97585196 |
| 111 | Growth hormone excess (HP:0000845) | 1.97111814 |
| 112 | Pulmonary embolism (HP:0002204) | 1.95860611 |
| 113 | Pustule (HP:0200039) | 1.95859375 |
| 114 | Hyperglycinuria (HP:0003108) | 1.94415008 |
| 115 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.93675615 |
| 116 | Abnormality of the nasal mucosa (HP:0000433) | 1.93119305 |
| 117 | Increased serum ferritin (HP:0003281) | 1.92837258 |
| 118 | Gastrointestinal inflammation (HP:0004386) | 1.92667179 |
| 119 | Abnormality of the gallbladder (HP:0005264) | 1.92306370 |
| 120 | Acanthocytosis (HP:0001927) | 1.92174986 |
| 121 | IgM deficiency (HP:0002850) | 1.92119009 |
| 122 | Keratitis (HP:0000491) | 1.92019271 |
| 123 | Polycythemia (HP:0001901) | 1.91590873 |
| 124 | Conjugated hyperbilirubinemia (HP:0002908) | 1.91467580 |
| 125 | Periodontitis (HP:0000704) | 1.90662056 |
| 126 | Upper motor neuron abnormality (HP:0002127) | 1.89520879 |
| 127 | Metaphyseal cupping (HP:0003021) | 1.89397444 |
| 128 | Agammaglobulinemia (HP:0004432) | 1.89300555 |
| 129 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.88971285 |
| 130 | Abnormal platelet function (HP:0011869) | 1.88493575 |
| 131 | Impaired platelet aggregation (HP:0003540) | 1.88493575 |
| 132 | Gastrointestinal stroma tumor (HP:0100723) | 1.87656443 |
| 133 | Eosinophilia (HP:0001880) | 1.86548144 |
| 134 | Difficulty running (HP:0009046) | 1.86333327 |
| 135 | Acute hepatic failure (HP:0006554) | 1.85346499 |
| 136 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.84202639 |
| 137 | Recurrent cutaneous fungal infections (HP:0011370) | 1.83515984 |
| 138 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.83515984 |
| 139 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.83141036 |
| 140 | Inflammation of the large intestine (HP:0002037) | 1.82332990 |
| 141 | Chronic otitis media (HP:0000389) | 1.82323789 |
| 142 | Hypermelanotic macule (HP:0001034) | 1.81137843 |
| 143 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.80522949 |
| 144 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.80276952 |
| 145 | Late onset (HP:0003584) | 1.80056464 |
| 146 | Abnormality of the common coagulation pathway (HP:0010990) | 1.79946488 |
| 147 | Granulocytopenia (HP:0001913) | 1.79778240 |
| 148 | Nasal polyposis (HP:0100582) | 1.79565228 |
| 149 | Recurrent pneumonia (HP:0006532) | 1.78652184 |
| 150 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.77707759 |
| 151 | Verrucae (HP:0200043) | 1.77627566 |
| 152 | Toxemia of pregnancy (HP:0100603) | 1.76463124 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 3.48074210 |
| 2 | MAP4K1 | 3.38516055 |
| 3 | GRK6 | 2.65664293 |
| 4 | MAP3K12 | 2.41341567 |
| 5 | BTK | 2.34622479 |
| 6 | PRPF4B | 2.30541355 |
| 7 | TAOK3 | 2.19416188 |
| 8 | TYK2 | 2.11845902 |
| 9 | TRIB3 | 2.09969064 |
| 10 | PKN2 | 2.05102252 |
| 11 | TAOK1 | 2.03599586 |
| 12 | EEF2K | 2.01607670 |
| 13 | DAPK2 | 2.00715812 |
| 14 | BCKDK | 1.99869730 |
| 15 | ZAP70 | 1.96017413 |
| 16 | MAP2K3 | 1.95513600 |
| 17 | MAP3K3 | 1.93751263 |
| 18 | KIT | 1.84571496 |
| 19 | CSK | 1.79207177 |
| 20 | MAP3K13 | 1.77551964 |
| 21 | MAP3K10 | 1.74136790 |
| 22 | ITK | 1.69438007 |
| 23 | SIK2 | 1.67868129 |
| 24 | DAPK1 | 1.67630123 |
| 25 | TEC | 1.62129601 |
| 26 | TXK | 1.61698694 |
| 27 | FGFR4 | 1.60677973 |
| 28 | IRAK4 | 1.60204907 |
| 29 | SYK | 1.59798540 |
| 30 | FGR | 1.56911721 |
| 31 | TNK2 | 1.52843692 |
| 32 | EPHB1 | 1.48592835 |
| 33 | JAK3 | 1.45979937 |
| 34 | FLT3 | 1.35165686 |
| 35 | RIPK4 | 1.33507458 |
| 36 | TBK1 | 1.33442563 |
| 37 | IKBKE | 1.28722180 |
| 38 | MARK2 | 1.26046514 |
| 39 | MATK | 1.25540002 |
| 40 | SGK3 | 1.23226948 |
| 41 | JAK2 | 1.20559370 |
| 42 | PRKD2 | 1.18516150 |
| 43 | MAPKAPK3 | 1.16954800 |
| 44 | MAPK11 | 1.16469313 |
| 45 | MAP3K11 | 1.13517871 |
| 46 | KSR2 | 1.09479524 |
| 47 | HCK | 1.08892471 |
| 48 | JAK1 | 1.07917752 |
| 49 | MAP3K9 | 1.06661027 |
| 50 | TAOK2 | 1.03773143 |
| 51 | CDK19 | 1.01837110 |
| 52 | CSF1R | 1.01452895 |
| 53 | TGFBR2 | 0.98302086 |
| 54 | PAK4 | 0.97023341 |
| 55 | SMG1 | 0.96081498 |
| 56 | FES | 0.95746351 |
| 57 | PRKCH | 0.94878493 |
| 58 | CAMKK2 | 0.94837784 |
| 59 | MAP2K6 | 0.91879633 |
| 60 | BLK | 0.91472560 |
| 61 | LCK | 0.89601271 |
| 62 | PIM1 | 0.88328174 |
| 63 | MAP3K1 | 0.87175482 |
| 64 | STK10 | 0.87008839 |
| 65 | SGK2 | 0.83621129 |
| 66 | SIK1 | 0.81605501 |
| 67 | MAP3K7 | 0.81464576 |
| 68 | MAP3K6 | 0.81420095 |
| 69 | PDK1 | 0.80003737 |
| 70 | PTK2B | 0.77460624 |
| 71 | IRAK2 | 0.77387070 |
| 72 | MAP2K4 | 0.76217902 |
| 73 | DAPK3 | 0.75630761 |
| 74 | STK38 | 0.73322962 |
| 75 | IRAK1 | 0.73038364 |
| 76 | SGK494 | 0.72564759 |
| 77 | SGK223 | 0.72564759 |
| 78 | DYRK1B | 0.72372791 |
| 79 | RIPK1 | 0.69211758 |
| 80 | KDR | 0.69195130 |
| 81 | STK4 | 0.68425967 |
| 82 | CDC42BPA | 0.68307997 |
| 83 | TTN | 0.67403106 |
| 84 | LYN | 0.67142396 |
| 85 | STK11 | 0.66470129 |
| 86 | CAMK4 | 0.64499985 |
| 87 | RPS6KA6 | 0.64186323 |
| 88 | RPS6KA2 | 0.63687954 |
| 89 | BRD4 | 0.63632280 |
| 90 | MAP3K14 | 0.63152120 |
| 91 | SIK3 | 0.61802941 |
| 92 | HIPK2 | 0.61255357 |
| 93 | TESK2 | 0.60661882 |
| 94 | LRRK2 | 0.60650522 |
| 95 | BMPR2 | 0.57429649 |
| 96 | MAPK4 | 0.57203975 |
| 97 | PDPK1 | 0.57114239 |
| 98 | MAPK7 | 0.55126640 |
| 99 | MYLK | 0.54550827 |
| 100 | MAP3K2 | 0.53636732 |
| 101 | IKBKB | 0.53279883 |
| 102 | RPS6KL1 | 0.51272348 |
| 103 | RPS6KC1 | 0.51272348 |
| 104 | CAMKK1 | 0.51058162 |
| 105 | CLK1 | 0.50437441 |
| 106 | YES1 | 0.50364028 |
| 107 | MAPK12 | 0.48988866 |
| 108 | PRKG2 | 0.47783986 |
| 109 | EPHA3 | 0.46857717 |
| 110 | NEK2 | 0.45440321 |
| 111 | BMX | 0.44047081 |
| 112 | MAP3K5 | 0.44011734 |
| 113 | FYN | 0.43735012 |
| 114 | INSRR | 0.42688995 |
| 115 | FGFR3 | 0.41804165 |
| 116 | PINK1 | 0.41348448 |
| 117 | MARK3 | 0.38926027 |
| 118 | RAF1 | 0.37994642 |
| 119 | RET | 0.36682021 |
| 120 | TRPM7 | 0.36206228 |
| 121 | PRKCQ | 0.35870662 |
| 122 | CDK4 | 0.35573206 |
| 123 | MAPKAPK2 | 0.35193558 |
| 124 | PRKCD | 0.34849579 |
| 125 | PRKCZ | 0.33757579 |
| 126 | KSR1 | 0.33260306 |
| 127 | NLK | 0.32876792 |
| 128 | PRKD1 | 0.32432238 |
| 129 | PTK6 | 0.31521550 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.51897970 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.03800822 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.74570966 |
| 4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.43611726 |
| 5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.34879826 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.21656569 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.19538418 |
| 8 | Allograft rejection_Homo sapiens_hsa05330 | 2.17586682 |
| 9 | Sulfur relay system_Homo sapiens_hsa04122 | 2.10931243 |
| 10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.09206932 |
| 11 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.04673541 |
| 12 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.03261263 |
| 13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.92113700 |
| 14 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.91629523 |
| 15 | Malaria_Homo sapiens_hsa05144 | 1.89481479 |
| 16 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.87196932 |
| 17 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.84708635 |
| 18 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.80160922 |
| 19 | ABC transporters_Homo sapiens_hsa02010 | 1.76002702 |
| 20 | Leishmaniasis_Homo sapiens_hsa05140 | 1.73463180 |
| 21 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.73431179 |
| 22 | Peroxisome_Homo sapiens_hsa04146 | 1.70344923 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.65111902 |
| 24 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.63571645 |
| 25 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.62777138 |
| 26 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.60714516 |
| 27 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.60634489 |
| 28 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.58154326 |
| 29 | Carbon metabolism_Homo sapiens_hsa01200 | 1.56275644 |
| 30 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.52286197 |
| 31 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.51112902 |
| 32 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.47138030 |
| 33 | Viral myocarditis_Homo sapiens_hsa05416 | 1.45351337 |
| 34 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.43015508 |
| 35 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.40485759 |
| 36 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.38724872 |
| 37 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.36765206 |
| 38 | Phagosome_Homo sapiens_hsa04145 | 1.35636906 |
| 39 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.34902053 |
| 40 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.34437550 |
| 41 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.33670116 |
| 42 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.32861046 |
| 43 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.30665001 |
| 44 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.28643209 |
| 45 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.27893419 |
| 46 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.26617645 |
| 47 | Platelet activation_Homo sapiens_hsa04611 | 1.26542905 |
| 48 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.26504046 |
| 49 | Other glycan degradation_Homo sapiens_hsa00511 | 1.23418134 |
| 50 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.22471173 |
| 51 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.22074737 |
| 52 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.21150607 |
| 53 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.20929366 |
| 54 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.16885994 |
| 55 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.16344508 |
| 56 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.11749213 |
| 57 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.11566105 |
| 58 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.05303778 |
| 59 | Hepatitis C_Homo sapiens_hsa05160 | 1.04891746 |
| 60 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.03491895 |
| 61 | Insulin resistance_Homo sapiens_hsa04931 | 1.03433300 |
| 62 | Hepatitis B_Homo sapiens_hsa05161 | 1.03128068 |
| 63 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.01652466 |
| 64 | Endocytosis_Homo sapiens_hsa04144 | 1.00600430 |
| 65 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.00175109 |
| 66 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.99982841 |
| 67 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.99338161 |
| 68 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.98870466 |
| 69 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.98857030 |
| 70 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.98699052 |
| 71 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.98031232 |
| 72 | Salmonella infection_Homo sapiens_hsa05132 | 0.96100684 |
| 73 | Pertussis_Homo sapiens_hsa05133 | 0.95665063 |
| 74 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.93516480 |
| 75 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.92659348 |
| 76 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.92136385 |
| 77 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.91634237 |
| 78 | Measles_Homo sapiens_hsa05162 | 0.91489577 |
| 79 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.89790945 |
| 80 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.88258125 |
| 81 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.86973222 |
| 82 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.83714234 |
| 83 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.83190610 |
| 84 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.82320222 |
| 85 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.82233141 |
| 86 | Asthma_Homo sapiens_hsa05310 | 0.80117129 |
| 87 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.79840832 |
| 88 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.79408551 |
| 89 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.77850199 |
| 90 | Lysosome_Homo sapiens_hsa04142 | 0.77734989 |
| 91 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.77527975 |
| 92 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.77479158 |
| 93 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.77003793 |
| 94 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.76418292 |
| 95 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.76292678 |
| 96 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.75381940 |
| 97 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.75372613 |
| 98 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.74931875 |
| 99 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.74653216 |
| 100 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.73811003 |
| 101 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.73318537 |
| 102 | Bile secretion_Homo sapiens_hsa04976 | 0.73093042 |
| 103 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.72776899 |
| 104 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.71971689 |
| 105 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.70756581 |
| 106 | Endometrial cancer_Homo sapiens_hsa05213 | 0.69014326 |
| 107 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.68683356 |
| 108 | Tuberculosis_Homo sapiens_hsa05152 | 0.68460663 |
| 109 | Galactose metabolism_Homo sapiens_hsa00052 | 0.68247303 |
| 110 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.67550118 |
| 111 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.66799966 |
| 112 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.66036295 |
| 113 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.65425358 |
| 114 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.65312160 |
| 115 | Amoebiasis_Homo sapiens_hsa05146 | 0.63094901 |
| 116 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.62703053 |
| 117 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.61583686 |
| 118 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.60942937 |
| 119 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.59539177 |
| 120 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.58770371 |
| 121 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.58270213 |
| 122 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.57924715 |
| 123 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.57521541 |
| 124 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.56833490 |
| 125 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.56136762 |
| 126 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.55990466 |
| 127 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.55825972 |
| 128 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.54835690 |
| 129 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.54827574 |
| 130 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.53910344 |
| 131 | Long-term potentiation_Homo sapiens_hsa04720 | 0.53849673 |
| 132 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.53318752 |
| 133 | Colorectal cancer_Homo sapiens_hsa05210 | 0.52787266 |
| 134 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.52783465 |
| 135 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.52408781 |
| 136 | Influenza A_Homo sapiens_hsa05164 | 0.51926682 |
| 137 | HTLV-I infection_Homo sapiens_hsa05166 | 0.50558653 |
| 138 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.49167889 |
| 139 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.48841400 |
| 140 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.48772148 |
| 141 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.48274144 |
| 142 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.47421681 |
| 143 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.47400689 |
| 144 | Lysine degradation_Homo sapiens_hsa00310 | 0.46207499 |
| 145 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.46205722 |
| 146 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.44996725 |
| 147 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.44368272 |
| 148 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.42923707 |
| 149 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.41786241 |
| 150 | Legionellosis_Homo sapiens_hsa05134 | 0.41574620 |
| 151 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.40653378 |
| 152 | Retinol metabolism_Homo sapiens_hsa00830 | 0.40100946 |
| 153 | DNA replication_Homo sapiens_hsa03030 | 0.39071804 |
| 154 | Shigellosis_Homo sapiens_hsa05131 | 0.38954645 |
| 155 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.38612882 |
| 156 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.37805269 |
| 157 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.36406465 |
| 158 | Apoptosis_Homo sapiens_hsa04210 | 0.35575488 |
| 159 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.34935958 |

